Analysts’ Viewpoint
Rise in prevalence of chronic diseases is expected to augment the global high flow oxygen therapy devices market during the forecast period. High flow oxygen therapy device is a type of respiratory support that provides high flow of oxygen-enriched air to patients having difficulty in breathing. Technological advancements in high-flow oxygen therapy equipment, such as compact design, portability, and improved patient comfort features, are driving market growth.
R&D of new devices is likely to offer lucrative opportunities to market players. Leading companies are launching advanced devices in order to increase their high flow oxygen therapy devices market share. However, high cost, lack of trained healthcare personnel, and patient discomfort are anticipated to hamper market statistics during the forecast period.
High flow oxygen therapy is a medical treatment that involves delivery of supplemental oxygen to a patient through a device that increases the flow and humidity of the oxygen. This therapy is used to treat patients with chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and bronchial asthma, as well as Acute Respiratory Distress Syndrome (ARDS). High flow oxygen therapy devices are available in two types: portable and standalone.
Increase in prevalence of chronic respiratory diseases is driving the global high flow oxygen therapy devices industry. Incidence of chronic respiratory diseases, such as COPD and asthma, is rising across the globe.
According to the World Health Organization (WHO), chronic respiratory disease was the third leading cause of death across the world in 2021. Around 65 million people globally have moderate to severe COPD.
Asthma affects an estimated 334 million people across the world, and the number is expected to increase in the next few years. Smoking is another significant factor driving the prevalence of chronic respiratory diseases. According to the WHO, tobacco smoking is the leading cause of COPD. It is also a major risk factor for the development of asthma. Furthermore, surge in usage of biomass fuels, such as wood and dung, for cooking and heating in low-income countries is boosting the prevalence of chronic respiratory diseases.
Innovations in design and functionality have made high flow oxygen therapy devices more user-friendly, portable, and efficient. Development of continuous flow systems is a key technological advancement that has accelerated market expansion. These systems provide constant flow of oxygen, which makes them ideal for patients with severe respiratory distress. Continuous flow systems have also been designed to be more compact and lightweight, and are ideal devices for usage in home-based healthcare and during transport.
Development of hybrid systems that combine high flow oxygen with non-invasive positive pressure ventilation (NIPPV) is another breakthrough technological advancement in the market. This combination allows for improved oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS), thereby reducing the risk of intubation and mechanical ventilation.
In terms of product type, the accessories segment held leading share of the global high flow oxygen therapy devices market in 2022. Rise in prevalence of chronic respiratory diseases is likely to drive the segment during the forecast period. Accessories of high flow oxygen therapy devices include nasal cannula and mask.
High flow nasal cannulas deliver heated and humidified oxygen to patient through a nasal cannula. These are designed to provide higher flow of oxygen than traditional humidified oxygen nasal cannulas and are used in the treatment of a range of respiratory conditions, including COPD, asthma, and pneumonia. Usage of high flow nasal cannulas has increased in the last few years due to their ability to deliver oxygen more efficiently and comfortably than traditional nasal cannulas.
High flow oxygen masks are used to treat patients with severe respiratory distress. They are often used in conjunction with non-invasive positive pressure ventilation (NIPPV). High flow oxygen masks have also become more popular in the past few years due to advancements in technology that have made these devices more user-friendly and efficient.
Based on application, the lung cancer segment is likely to account for major share of the global high flow oxygen therapy devices market during the forecast period. Lung cancer is the leading cause of cancer deaths worldwide, accounting for approximately one in four cancer deaths.
Increase in number of cases of lung cancer, rise in global population, and aging population are expected to drive the demand for lung cancer treatment. Additionally, advancements in treatment options, such as targeted therapy and immunotherapy, which have improved patient outcomes, are expected to bolster the segment in the next few years.
North America held the largest share of around 35.0% of the global high flow oxygen therapy devices market demand in 2022. The region is projected to be a highly lucrative market during the forecast period. North America's global dominance can be ascribed to the increase in incidence chronic diseases. The U.S. dominated the market in the region owing to factors such as presence of leading players and increase in research & development activities in high flow oxygen therapy devices.
Asia Pacific is projected to be the fastest growing market for high flow oxygen therapy devices during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2022 to 2031 due to high incidence rate and increasing population.
The global high flow oxygen therapy devices market is fragmented, with the presence of large number of players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by the leading players.
GE HealthCare, Koninklijke Philips N.V, ResMed, Fisher & Paykel Healthcare, Hamilton Medical, Besmed Health Business Corp, Linde Healthcare, BMC Medical, Movair, and VYAIRE Medical are the prominent players operating in the market.
Each of these players has been profiled in the high flow oxygen therapy devices market report based on parameters such as company overview, strategies, portfolio, segments, and recent developments.
Attribute |
Detail |
Size in 2022 |
US$ 1.7 Bn |
Forecast (Value) in 2031 |
More than US$ 1.4 Bn |
Growth Rate (CAGR) |
-2.4% |
Forecast Period |
2023–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Bn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global industry was valued at US$ 1.7 Bn in 2022
It is projected to reach more than US$ 1.4 Bn by 2031
The CAGR is anticipated to be -2.4% from 2023 to 2031
Rise in prevalence of chronic diseases and technological advancements
North America is likely to account for leading share during the forecast period
GE HealthCare, Koninklijke Philips N.V, ResMed, Fisher & Paykel Healthcare, Hamilton Medical, Besmed Health Business Corp, Linde Healthcare, BMC Medical, Movair, and VYAIRE Medical
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global High Flow Oxygen Therapy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Key Product/Brand Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Portable Devices
6.3.2. Standalone Devices (Reservoir)
6.3.3. Accessories
6.3.3.1. High-flow Nasal Cannula
6.3.3.2. High-flow Face Mask (HFFM)
6.3.3.3. Respiratory Humidifier
6.3.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Lung Cancer
7.3.2. COPD
7.3.3. Asthma
7.3.4. Heart Failure
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global High Flow Oxygen Therapy Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America High Flow Oxygen Therapy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Portable Devices
10.2.2. Standalone Devices (Reservoir)
10.2.3. Accessories
10.2.3.1. High-flow Nasal Cannula
10.2.3.2. High-flow Face Mask (HFFM)
10.2.3.3. Respiratory Humidifier
10.2.3.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Lung Cancer
10.3.2. COPD
10.3.3. Asthma
10.3.4. Heart Failure
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe High Flow Oxygen Therapy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Portable Devices
11.2.2. Standalone Devices (Reservoir)
11.2.3. Accessories
11.2.3.1. High-flow Nasal Cannula
11.2.3.2. High-flow Face Mask (HFFM)
11.2.3.3. Respiratory Humidifier
11.2.3.4. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Lung Cancer
11.3.2. COPD
11.3.3. Asthma
11.3.4. Heart Failure
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific High Flow Oxygen Therapy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Portable Devices
12.2.2. Standalone Devices (Reservoir)
12.2.3. Accessories
12.2.3.1. High-flow Nasal Cannula
12.2.3.2. High-flow Face Mask (HFFM)
12.2.3.3. Respiratory Humidifier
12.2.3.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Lung Cancer
12.3.2. COPD
12.3.3. Asthma
12.3.4. Heart Failure
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America High Flow Oxygen Therapy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Portable Devices
13.2.2. Standalone Devices (Reservoir)
13.2.3. Accessories
13.2.3.1. High-flow Nasal Cannula
13.2.3.2. High-flow Face Mask (HFFM)
13.2.3.3. Respiratory Humidifier
13.2.3.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Lung Cancer
13.3.2. COPD
13.3.3. Asthma
13.3.4. Heart Failure
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa High Flow Oxygen Therapy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Portable Devices
14.2.2. Standalone Devices (Reservoir)
14.2.3. Accessories
14.2.3.1. High-flow Nasal Cannula
14.2.3.2. High-flow Face Mask (HFFM)
14.2.3.3. Respiratory Humidifier
14.2.3.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Lung Cancer
14.3.2. COPD
14.3.3. Asthma
14.3.4. Heart Failure
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. GE HealthCare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Koninklijke Philips N.V
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. ResMed
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Fisher & Paykel Healthcare
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Hamilton Medical
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. Besmed Health Business Corp
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.7. Linde Healthcare
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. BMC Medical
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. VYAIRE Medical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Movair
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
List of Tables
Table 01: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global High Flow Oxygen Therapy Devices Market Value Share, by Product Type (2022)
Figure 03: Global High Flow Oxygen Therapy Devices Market Value Share, by End-user (2022)
Figure 04: Global High Flow Oxygen Therapy Devices Market Value Share, by Application (2022)
Figure 05: Global High Flow Oxygen Therapy Devices Market Value Share, by Region (2022)
Figure 06: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 07: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 08: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 09: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 10: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 11: Global High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 12: Global High Flow Oxygen Therapy Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 13: Global High Flow Oxygen Therapy Devices Market Attractiveness, by Region, 2022-2031
Figure 14: North America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 15: North America High Flow Oxygen Therapy Devices Market Value Share (%), by Country, 2022 and 2031
Figure 16: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Country, 2023–2031
Figure 17: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 18: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 19: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 20: North America High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 21: North America High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 22: North America High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 23: Europe High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: Europe High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 25: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 26: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 27: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 28: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 29: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 30: Europe High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 31: Europe High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 32: Asia Pacific High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 33: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 34: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 35: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 36: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 37: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 38: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 39: Asia Pacific High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Asia Pacific High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 41: Latin America High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 42: Latin America High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 43: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 44: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 45: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 46: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 47: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 48: Latin America High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 49: Latin America High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 50: Middle East & Africa High Flow Oxygen Therapy Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 52: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Country/Sub-region, 2023–2031
Figure 53: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 54: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Product Type, 2023–2031
Figure 55: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 56: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by Application, 2023–2031
Figure 57: Middle East & Africa High Flow Oxygen Therapy Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 58: Middle East & Africa High Flow Oxygen Therapy Devices Market Attractiveness, by End-user, 2023–2031
Figure 59: Global High Flow Oxygen Therapy Devices Market Share Analysis, by Company, 2021